A roadmap for discovery and translation in lymphoma

Blood

Volumn 125, Issue 13, 2015, Pages 2175-2177

  Weinstock, David M ^a   Dalla Favera, Riccardo ^b   Gascoyne, Randy D ^c   Leonard, John P ^d   Levy, Ronald ^e   Lossos, Izidore S ^f   Melnick, Ari M ^d   Nowakowski, Grzegorz S ^g   Press, Oliver W ^h   Savage, Kerry J ⁱ   Shipp, Margaret A ^a   Staudt, Louis M ^j  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NewYork Presbyterian Hospital   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

^e STANFORD UNIVERSITY   (United States)

^f UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^g MAYO CLINIC   (United States)

^h Fred Hutchinson Cancer Research Center   (United States)

ⁱ BRITISH COLUMBIA CANCER AGENCY   (Canada)

^j NATIONAL CANCER INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

MYC PROTEIN; PROTEIN BCL 2;

CANCER PATIENT; CELL DIFFERENTIATION; CHRONIC LYMPHATIC LEUKEMIA; HODGKIN DISEASE; HUMAN; LARGE CELL LYMPHOMA; LETTER; LYMPHOMA; NONHODGKIN LYMPHOMA; PERIPHERAL T CELL LYMPHOMA; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TUMOR XENOGRAFT; COOPERATION; GENETIC ASSOCIATION; MEDICAL RESEARCH; MOLECULARLY TARGETED THERAPY; ORGANIZATION AND MANAGEMENT; PROCEDURES; RESEARCH; TRANSLATIONAL RESEARCH; TRENDS;

BIOMEDICAL RESEARCH; COOPERATIVE BEHAVIOR; GENETIC ASSOCIATION STUDIES; HUMANS; LYMPHOMA; MOLECULAR TARGETED THERAPY; RESEARCH; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84926171962     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2015-01-623777     Document Type: Letter

References (8)

1. Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, Jaffe ES. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood. 2011;117(19):5019-5032.
2. Oettgen HF, Clifford P, Burkitt D. Malignant lymphoma involving the jaw in African children: treatment with alkylating agents and actinomycin D. Cancer Chemother Rep. 1963;28:25-34.
3. Coiffier B, Lepage E, Briere J, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med. 2002;346(4):235-242.
4. Rooney CM, Smith CA, Ng CY, et al. Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation. Lancet. 1995;345(8941):9-13.
5. Pescatore P, Heine M, Manegold BC. Cure of gastric lymphoma with antibiotics. Gastroenterology. 1995;109(1):334-335.
6. Ansell SM, Lesokhin AM, Borrello I, et al. PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma. N Engl J Med. 2015;372(4):311-319.
7. Kalos M, Levine BL, Porter DL, et al. T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia. Sci Transl Med. 2011;3(95):95ra73.
8. Bollard CM, Gottschalk S, Torrano V, et al. Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins. J Clin Oncol. 2014;32(8):798-808.